Free shipping on all orders over $ 500

HSP Heat shock proteins

Cat.No.  Name Information
M1725 CUDC-305 CUDC-305 is a heat shock protein 90 (HSP90) inhibitor of the novel imidazopyridine class.
M7575 Apoptozole Apoptozole is an inhibitor of the ATPase domain of Hsc70 and Hsp70, with Kds of 0.21 and 0.14 μM, respectively, and can induce apoptosis.
M9899 Arimoclomol maleate Arimoclomol maleate (also known as BRX-220) is a heat shock protein amplifier, and is potentially useful for the treatment of Niemann-Pick disease type C (NP-C).
M9273 HSP70-IN-1 HSP70-IN-1 is a heat shock protein (HSP) inhibitor with an IC50 of 2.3 μM inhibiting the growth of Kasumi-1 cells.
M1798 NVP-HSP990 NVP-HSP990 is an orally bioavailable inhibitor of human heat-shock protein 90 (Hsp90) with potential antineoplastic activity.
M1741 Ganetespib Ganetespib (STA-9090) is a potent synthetic small molecule inhibitor of Hsp90 with potential antineoplastic activity.
M7427 TRC 051384 TRC 051384 is a inducer of heat shock protein Hsp70.
M6872 KRIBB11 KRIBB11 is a hSF1 inhibitor.
M6571 CCT 018159 CCT 018159 is a hsp90 inhibitor.
M6512 BiP inducer X BiP inducer X (BIX) is a selective inducer of immunoglobulin heavy chain binding protein (BiP)/GRP78. BiP inducer X (BIX) is also an effective ER (endoplasmic reticulum) stress inhibitor.
M5997 Teprenone Teprenone(Geranylgeranylacetone; GGA)is commonly utilized to protect the gastric mucosa in peptic ulcer disease; has been shown to protect the myocardium from ischemia/reperfusion by activating heat shock proteins.
M4618 Eupalinolide A Eupalinolide A, isolated from Eupatorium lindleyanum, induces the expression of HSP70 via the activation of HSF1 by inhibiting the interaction between HSF1 and HSP90.
M3776 CH5138303 CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
M3683 Retaspimycin Retaspimycin is a novel, water-soluble, potent inhibitor of heat-shock protein 90 (Hsp90).
M3563 KW-2478 KW-2478 is a nonansamycin HSP90 inhibitor with IC50 of 3.8 nM.
M3561 Geldanamycin Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.
M3528 SNX-2112 SNX-2112 selectively binds to the ATP pocket of HSP90α and HSP90β with Ka of 30 nM and 30 nM, uniformly more potent than 17-AAG.
M3197 MPC-3100 MPC-3100 is a fully synthetic and potent Hsp90 inhibitor with IC50 of 60 nM.
M3117 VER-49009 VER-49009 is a potent HSP90 inhibitor with IC50 of 47 nM for HSP90β.
M3116 VER 155008 VER-155008 is a potent inhibitor of the HSP70 family, with IC50 of 0.5 μM and 2.6 μM for HSP70 and Grp78, respectively, exhibits >100-fold selectivity over HSP90.
M2885 NMS-E973 NMS-E973 is a potent and selective Hsp90 inhibitor with DC50 of <10 nM for Hsp90 binding, no activiy against a panel of 52 diverse protein kinases.
M2777 IPI-504 hydrochloride IPI-504 (Retaspimycin) hydrochloride is a potent inhibitor of HSP90 with EC50 of 63 nM.
M2776 IPI-493 IPI-493 is a potent and orally bioavailable HSP90 inhibitor with Ki of 21 nM.
M2321 17-DMAG (Alvespimycin) hydrochloride 17-DMAG (Alvespimycin, KOS-1022, NSC 707545) hydrochloride is a potent HSP90 inhibitor with IC50 of 62 nM.
M2320 17-AAG (Tanespimycin) 17-AAG (Tanespimycin) is a potent HSP90 inhibitor with IC50of 5 nM.
M2070 XL888 XL888 is a novel small-molecule inhibitor of HSP90 with IC50 of 24 nM.




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.